ArticleFrontiers in genetics2026
Carrier frequency of autosomal recessive monogenic disorders in the peruvian population.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Autosomal recessive diseases represent an important group of genetic disorders whose frequency may be reduced through population screening strategies or premarital diagnosis, particularly in low- and middle-income countries, where some of these conditions have personalized treatment options that are often not covered by healthcare systems. The aim of this study was to determine the frequency of carriers of autosomal recessive monogenic disorders among patients who underwent exome sequencing at a national pediatric referral hospital in Peru. Materials and Methods: An observational study was conducted in which carrier frequency was calculated based on pathogenic or likely pathogenic variants identified through exome sequencing. Additionally, assumptions from the Hardy-Weinberg equilibrium were applied to estimate the expected frequency of affected individuals in the population. Exploratory analyses were performed to estimate the odds ratio to evaluate the possible association between the geographic origin of patients or their grandparents and the presence of recessive variants. Results: The sample included 178 patients who underwent exome sequencing. In the analyzed cohort, approximately one pathogenic or likely pathogenic heterozygous variant per individual was identified, and at least 63.5% of participants were carriers of at least one genetic condition. Conclusion: Carrier frequencies for genes such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.